Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 3155462)

Published in J Immunol on January 01, 1985

Authors

T G Mayer, A A Fuller, T C Fuller, A I Lazarovits, L A Boyle, J T Kurnick

Articles citing this

Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol (1986) 2.84

Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A (1988) 2.36

Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells. J Exp Med (1990) 1.15

Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 1.08

T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest (1986) 0.98

Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94

ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87

Decreased expression of CD7 occurs in rheumatoid arthritis. Clin Exp Immunol (1988) 0.87

Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis. Clin Exp Immunol (1990) 0.85

Serine esterase and hemolytic activity in human cloned cytotoxic T lymphocytes. J Exp Med (1988) 0.81

T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients. Clin Exp Immunol (1994) 0.80

Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood. Clin Exp Immunol (1992) 0.78

Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells. Immunology (1994) 0.75

In vitro assessment of FK 506 immunosuppressive activity in transplant patients. Transplant Proc (1991) 0.75

Development and characterisation of T lymphocyte lines from human small intestinal biopsies. Gut (1989) 0.75

Articles by these authors

HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science (1988) 3.12

Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells. J Immunol (1984) 2.84

A prospective two-year study of functional restoration in industrial low back injury. An objective assessment procedure. JAMA (1987) 2.75

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med (1994) 2.72

Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A (1988) 2.36

A rapid method for the separation of functional lymphoid cell populations of human and animal origin on PVP-silica (Percoll) density gradients. Scand J Immunol (1979) 2.35

The dominant role of psychosocial risk factors in the development of chronic low back pain disability. Spine (Phila Pa 1976) (1995) 2.28

Objective assessment of spine function following industrial injury. A prospective study with comparison group and one-year follow-up. Spine (Phila Pa 1976) (1986) 2.26

Long term growth in vitro of human T cell blasts with maintenance of specificity and function. J Immunol (1979) 2.25

Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes. J Immunol (1994) 2.09

Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J Clin Invest (1997) 1.98

Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism. J Immunol (1993) 1.92

Propagation of antigen-specific T cell helper function in vitro. J Immunol (1979) 1.88

Studies on the mode of action of diphtheria toxin. VII. Toxin-stimulated hydrolysis of nicotinamide adenine dinucleotide in mammalian cell extracts. J Exp Med (1969) 1.83

Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen. J Immunol (1984) 1.60

Use of noninvasive techniques for quantification of spinal range-of-motion in normal subjects and chronic low-back dysfunction patients. Spine (Phila Pa 1976) (1984) 1.59

Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. J Immunol (1983) 1.57

1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest (1984) 1.52

Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin. J Immunol (1977) 1.52

Psychiatric illness and chronic low-back pain. The mind and the spine--which goes first? Spine (Phila Pa 1976) (1993) 1.47

A prospective study of Waddell signs in patients with chronic low back pain. When they may not be predictive. Spine (Phila Pa 1976) (1997) 1.42

Functional restoration. Pitfalls in evaluating efficacy. Spine (Phila Pa 1976) (1992) 1.39

Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol (1987) 1.38

Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34

Relationship between immunoglobulin-bearing lymphocytes and cells reactive with sensitized human erythrocytes. J Immunol (1975) 1.32

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet (1989) 1.28

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation (1986) 1.24

Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. J Immunol (1985) 1.20

Influence of residential fungal contamination on peripheral blood lymphocyte populations in children. Arch Environ Health (1998) 1.16

Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes. J Immunol (1993) 1.15

Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells. J Exp Med (1990) 1.15

Helper and suppressor-inducer activity of human T cells and their cloned progeny maintained in long-term culture. J Immunol (1981) 1.12

Structure-function analysis of the integrin beta 7 subunit: identification of domains involved in adhesion to MAdCAM-1. J Immunol (1997) 1.10

Quantification of lumbar function. Part 2: Sagittal plane trunk strength in chronic low-back pain patients. Spine (Phila Pa 1976) (1985) 1.10

Modulation of synovial cell products by a factor from a human cell line: T lymphocyte induction of a mononuclear cell factor. Proc Natl Acad Sci U S A (1982) 1.09

Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant. Eur J Immunol (1982) 1.09

Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 1.08

Antigenic polymorphism of the T4 differentiation antigen expressed on human T helper/inducer lymphocytes. Hum Immunol (1984) 1.06

Human intestinal B-cell blasts and plasma cells express the mucosal homing receptor integrin alpha 4 beta 7. Scand J Immunol (1995) 1.05

Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci (1974) 1.05

PHA-induced activation of suppressor cells in normal human peripheral blood lymphocytes. Scand J Immunol (1976) 1.04

Quantification of lumbar function. Part 5: Reliability of range-of-motion measures in the sagittal plane and an in vivo torso rotation measurement technique. Spine (Phila Pa 1976) (1986) 1.03

Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation (1982) 1.01

Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology (1996) 1.00

Release of gram-negative outer-membrane proteins into human serum and septic rat blood and their interactions with immunoglobulin in antiserum to Escherichia coli J5. J Infect Dis (2000) 0.99

Prospective randomized trial of azathioprine in cryopreserved valved allografts in children. Ann Thorac Surg (2001) 0.99

Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition. Cancer Res (1991) 0.99

Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother (1987) 0.99

Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. Infect Immun (2000) 0.98

Improved physical performance outcomes after functional restoration treatment in patients with chronic low-back pain. Early versus recent training results. Spine (Phila Pa 1976) (1990) 0.98

T cell receptors in rheumatoid arthritis. Arthritis Rheum (1995) 0.97

Functional characterization of T lymphocytes propagated from human lung carcinomas. Clin Immunol Immunopathol (1986) 0.97

Psychopathology and the rehabilitation of patients with chronic low back pain disability. Arch Phys Med Rehabil (1994) 0.96

Immunity to antigens associated with primate C-type oncoviruses in pregnant women. Science (1978) 0.96

Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation (1982) 0.95

Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol (1987) 0.94

Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci U S A (1998) 0.94

A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter. J Immunol (2001) 0.93

Immunochemical and biologic characterization of alloantibody active in immunologic enhancement. Transplant Proc (1973) 0.93

Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg (2000) 0.92

T cell growth factor-enhanced PHA response of human thymus cells: requirement for T3+ cells. J Immunol (1981) 0.92

T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation. Clin Immunol Immunopathol (1983) 0.92

Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med (1982) 0.92

Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol (1997) 0.91

Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation. J Immunol (1986) 0.91

Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria. J Infect Dis (1997) 0.91

Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant (2001) 0.91

Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. J Rheumatol (1998) 0.91

Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. J Immunol (1989) 0.91

A minor subset of HLA-DR3 haplotypes is preferentially increased in type 1 (insulin-dependent) diabetes. Diabetologia (1985) 0.90

In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites. Proc Natl Acad Sci U S A (1997) 0.90

Adoptively transferable tolerance induced by CD45RB monoclonal antibody. J Am Soc Nephrol (1999) 0.90

Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. Scand J Gastroenterol (1998) 0.90

Expression of the mucosal homing receptor alpha 4 beta 7 in malignant lymphomatous polyposis of the intestine. Gastroenterology (1994) 0.90

Strategies to overcome obstacles to successful immunotherapy of melanoma. Int J Immunopathol Pharmacol (2008) 0.90

Frozen blood in transplant patients: hepatitis and HL-A isosensitization. Transplant Proc (1973) 0.90

Myoelectric spectral analysis and strategies for quantifying trunk muscular fatigue. Arch Phys Med Rehabil (1987) 0.89

Differentiation between somatic and cognitive/affective components in commonly used measurements of depression in patients with chronic low-back pain. Let's not mix apples and oranges. Spine (Phila Pa 1976) (1991) 0.89

A prospective short-term study of chronic low back pain patients utilizing novel objective functional measurement. Pain (1986) 0.89

Fatal systemic fluorosis due to hydrofluoric acid burns. Ann Emerg Med (1985) 0.89

Specific regulation of VLA-4 and alpha 4 beta 7 integrin expression on human activated T lymphocytes. J Immunol (1996) 0.88

Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma. Cancer (1992) 0.88

Escherichia coli and Pseudomonas aeruginosa induce expansion of V delta 2 cells in adult peripheral blood, but of V delta 1 cells in cord blood. J Immunol (1996) 0.88

The outcome of pregnancy following renal transplantation--the experience of a single center. Transplantation (1992) 0.87

Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer (1992) 0.87

Functional analysis of T cell subsets and clones in human renal allograft rejection. Transplant Proc (1987) 0.87